In a recent breakthrough in cancer research, scientists have found two types of personalized vaccines to be “safe and effective” in initial human clinical trials. According to a Reuters report, the vaccines successfully stopped the re-occurrence of cancer in 12 out of 19 melanoma patients within 2 years of treatment. Results of the trials were published on the scientific journal …